Adaptation to the coupling of glycolysis to toxic methylglyoxal production in <i>tpiA</i> deletion strains of <i>Escherichia coli</i> requires synchronized and counterintuitive genetic changes by McCloskey, Douglas et al.
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Oct 26, 2019
Adaptation to the coupling of glycolysis to toxic methylglyoxal production in tpiA
deletion strains of Escherichia coli requires synchronized and counterintuitive genetic
changes
McCloskey, Douglas; Xu, Sibei; Sandberg, Troy E.; Brunk, Elizabeth; Hefner, Ying; Szubin, Richard;
Feist, Adam M.; Palsson, Bernhard O.
Published in:
Metabolic Engineering
Link to article, DOI:
10.1016/j.ymben.2018.05.012
Publication date:
2018
Document Version
Peer reviewed version
Link back to DTU Orbit
Citation (APA):
McCloskey, D., Xu, S., Sandberg, T. E., Brunk, E., Hefner, Y., Szubin, R., ... Palsson, B. O. (2018). Adaptation
to the coupling of glycolysis to toxic methylglyoxal production in tpiA deletion strains of Escherichia coli requires
synchronized and counterintuitive genetic changes. Metabolic Engineering, 48, 82-93.
https://doi.org/10.1016/j.ymben.2018.05.012
Author’s Accepted Manuscript
Adaptation to the coupling of glycolysis to toxic
methylglyoxal production in tpiA deletion strains of
Escherichia coli requires synchronized and
counterintuitive genetic changes
Douglas McCloskey, Sibei Xu, Troy E. Sandberg,
Elizabeth Brunk, Ying Hefner, Richard Szubin,
Adam M. Feist, Bernhard O. Palsson
PII: S1096-7176(18)30063-6
DOI: https://doi.org/10.1016/j.ymben.2018.05.012
Reference: YMBEN1410
To appear in: Metabolic Engineering
Received date: 9 February 2018
Revised date: 3 May 2018
Accepted date: 23 May 2018
Cite this article as: Douglas McCloskey, Sibei Xu, Troy E. Sandberg, Elizabeth
Brunk, Ying Hefner, Richard Szubin, Adam M. Feist and Bernhard O. Palsson,
Adaptation to the coupling of glycolysis to toxic methylglyoxal production in
tpiA deletion strains of Escherichia coli requires synchronized and
counterintuitive genetic changes, Metabolic Engineering,
https://doi.org/10.1016/j.ymben.2018.05.012
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
www.elsevier.com/locate/ymben
 1 
 
Adaptation to the coupling of glycolysis to toxic methylglyoxal production in tpiA deletion strains 
of Escherichia coli requires synchronized and counterintuitive genetic changes 
Douglas McCloskey1,2, Sibei Xu1, Troy E. Sandberg1, Elizabeth Brunk1, Ying Hefner1, Richard 
Szubin1, Adam M. Feist1,2, , and Bernhard O. Palsson1,2,* 
1Department of Bioengineering, University of California - San Diego, La Jolla, CA 92093, USA. 
2Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 
Lyngby, Denmark. 
*Corresponding author, Department of Bioengineering, University of California, San Diego, 9500 
Gilman Drive, La Jolla, CA 92093-0412, USA. Tel.: 858-534-5668; Fax: 858-822-3120. 
palsson@ucsd.edu 
 
Abstract  
Methylglyoxal is a highly toxic metabolite that can be produced in all living organisms.  
Methylglyoxal was artificially elevated by removal of the tpiA gene from a growth optimized 
Escherichia coli strain. The initial response to elevated methylglyoxal and its toxicity was 
characterized, and detoxification mechanisms were studied using adaptive laboratory evolution. 
We found that: 1) Multi-omics analysis revealed biological consequences of methylglyoxal 
toxicity, which included attack on macromolecules including DNA and RNA and perturbation of 
nucleotide levels; 2) Counter-intuitive cross-talk between carbon starvation and inorganic 
phosphate signalling was revealed in the tpiA deletion strain that required mutations in inorganic 
phosphate signalling mechanisms to alleviate; and 3) The split flux through lower glycolysis 
depleted glycolytic intermediates requiring a host of synchronized and coordinated mutations in 
non-intuitive network locations in order to re-adjust the metabolic flux map to achieve optimal 
                                               
 Adaptive laboratory evolution, tpiA gene knockout, mutation analysis, multi-omics data integration, 
systems biology, E. coli 
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growth.  Such mutations included a systematic inactivation of the Phosphotransferase System 
(PTS) and alterations in cell wall biosynthesis enzyme activity.  This study demonstrated that 
deletion of major metabolic genes followed by ALE was a productive approach to gain novel 
insight into the systems biology underlying optimal phenotypic states. 
Introduction 
Methylglyoxal (mthgxl) is a highly toxic metabolite that can be produced in all living organisms, 
and is directly linked to sugar metabolism.  Methylglyoxal is highly cytotoxic owing to keto and 
aldehyde groups that can readily react with nearby metabolites and exposed units of 
macromolecules.  For example, the keto and aldehyde groups can bind covalently to 
macromolecules such as DNA and proteins to form advanced glycation end products (AGEs) 
(Basta et al., 2004; Goldin et al., 2006; Singh et al., 2001; Thomas, 2011).   Methylglyoxal is 
also mutagenic, and has been shown to interact with DNA through direct binding of guanine 
residues (Kasai et al., 1982; Murata-Kamiya et al., 1999).  Due to the potential for methylglyoxal 
generation in all living organisms and its toxic effects to the cell, a greater understanding of its 
toxicity and mechanisms of detoxification are needed.   
 
Methylglyoxal can be formed as a side product of glycolysis via the methylglyoxal pathway 
(Saadat and Harrison, 1999; Weber et al., 2005).  Methylglyoxal  levels can be artificially 
increased by bifurcating flux through lower glycolysis by removing the tpiA gene.  tpiA encodes 
the Triosephosphate Isomerase (TPI) that is responsible for isomerizing dihydroxyacetone 
phosphate (dhap) to glyceraldehyde-3-phosphate (g3p).  Loss of TPI forces dhap to be 
metabolized by the methylglyoxal pathway instead of the enzymes of lower glycolysis, which 
generates methylglyoxal.  Removal of tpiA has been used in biotechnology applications to 
increase production of 1,2-propanediol, which has high commercial utility in the production of 
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polymers (Shelley, 2007).  Additional studies have also identified genes in potassium transport 
that allow for cells to better cope with exposure to methyglyxoal (Ozyamak et al., 2013).  Further 
studies that both reveal genetic interventions for how to optimize flux through the methylglyoxal 
pathway and allow the cell to rapidly detoxify methylglyoxal are needed for efficient production 
of methylglyoxal derived compounds. 
 
Flux through the methylglyoxal pathway for production of methylglyoxal derived compounds for 
biotechnology applications can be optimized by adaptive laboratory evolution (ALE) (Fong et al., 
2006).  ALE is an experimental approach that introduces a selection pressure (e.g., growth rate 
selection) in a controlled environmental setting (Dragosits and Mattanovich, 2013; Plucain et al., 
2014; Tenaillon et al., 2016).  Using ALE, organisms can be perturbed from their evolutionary 
optimized homeostatic states, and their re-adjustment to a new growth condition can be studied. 
Monitoring cellular changes during the course of adaptation can reveal novel and non-intuitive 
component functions and interactions that can then be re-engineered into a host organism.  ALE 
of tpiA mutants found an increase in flux capacity through the methylglyoxal pathway (Fong et 
al., 2006), however, a systems level understanding of methylglyoxal detoxification as a result of 
mutations that appeared during ALE were not revealed. 
 
In this study, the effects of methlyglyoxal toxicity on cellular functions were investigated by 
removing the tpiA gene from a growth optimized E. coli strain (LaCroix et al., 2015).  The 
consequences of increased level of methylglyoxal was studied in the tpiA knock-out strains, that 
was then evolved to tolerance using ALE.  Multi-omic data analysis revealed biochemical 
evidence of methylglyoxal toxicity and genetic changes that upregulated mechanisms to 
overcome its toxic effects.  
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Results 
tpiA KO 
In order to eliminate the confounding variable of adaptation to the growth conditions of the 
experiment, a starting strain in which the gene KO was implemented was carefully chosen.  A 
wild-type E. coli K-12 MG1655 strain previously evolved under glucose minimal media at 37°C 
(LaCroix et al., 2015) (denoted as “Ref”) was selected in order to minimize biological changes 
caused by adaption to the loss of a gene product from those caused by adaption to the growth 
conditions of the experiment.    
 
TPI (tpiA, Triosphosphate Isomerase) was removed from Ref to generate strain uTpiA (denoted 
“unevolved tpiA knockout strain”).  The loss of tpiA resulted in an 80% loss in growth rate (Fig. 
1D).  Four uTpiA independently-inoculated starting cultures were simultaneously evolved on 
glucose minimal media at 37°C in an automated ALE platform (LaCroix et al., 2015; Sandberg 
et al., 2014) to generate endpoint strains, denoted “evolved tpiA knockout strains” or “eTpiA”.  A 
statistically significant increase in final fitness (Student’s t-test, pvalue<0.05) was found in all 
ALE endpoints of the eTpiA lineages (ave±stdev 164±7% increase in fitness) compared to 
uTpiA.   
Loss of tpiA activated the glyoxylate pathways 
Fructose 1,6-bisphosphate (fdp) from upper glycolysis is split into dihydroxyacetone phosphate 
(dhap) and glyceraldehyde-3-phosphate (g3p) by fructose-bisphosphate aldolase (FBA) (Fig. 
2A).  g3p can be directly processed down the enzymatic machinery of lower glycolysis, but dhap 
must first be isomerized by Triosephosphate Isomerase (TPI) to g3p before glyceraldehyde 
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phosphate dehydrogenase (GAPD) can catalyze the first step of lower glycolysis (Fig. 2A).  
Loss of enzymatic interconversion by TPI thus bifurcates glycolysis into lower glycolysis  and 
pathways that degrade dhap, that involve methylglyoxal formation. 
 
Reaction fluxes estimated from C13 labeling experiments and estimated using Genome-scale 
Metabolic Flux Analysis (MFA) (McCloskey et al., 2016a, 2016b) found that upper glycolytic flux 
was approximately evenly split between lower glycolysis and the methylglyoxal pathway in 
uTpiA (Fig 2B).  LC-MS/MS-based metabolomics (McCloskey et al., 2015, 2014) found that 
bifurcation of lower glycolysis also led to an approximate 3.55 log2 fold change buildup of dhap 
in uTpiA compared to Ref (Table S3).  While not measured directly, LC-MS/MS analysis was 
able to measure the amounts of methylglyoxal break down products, which indicate an elevation 
in methylglyoxal (Fig. S2).  An end product of the methylglyoxal pathway is D/L-Lactate (lac-DL), 
which can then be converted back to pyruvate (pyr), the end product of lower glycolysis, by 
lactate dehydrogenase (LDH) (Fig. 2C).  Minimal amounts of intracellular lac-DL and no 
detectable lac-DL excretion coupled with overexpression of lldD and 1.67 mmol*gDCW-1*hr-1 
flux through LDH (approximately the same amount of flux through MGSA), indicated that the 
majority of lac-DL produced was converted back to pyr in uTpiA (Fig. 2D-E).   
 
E. coli has four paths (Fig. 3A) to metabolize methylglyoxal: paths 1 and 2 lead to the production 
of  propane 1,2-diol (12ppd-R), and paths 3 and 4 lead to the production of lac-DL. Unlike lac-
DL, E. coli has no known enzyme to process 12ppd-R and hence it can only be excreted out of 
the cell.  RNA sequencing revealed that in uTpiA paths 1 and 2 were primarily activated with 
minor contribution from path 3 and no contribution from path 4 (Fig. 3B).  In contrast, path 4 was 
highly activated in all eTpiA strains with varying degrees of path 2 and path 3 activation.  Based 
on expression profiling and metabolomics measurements, it appears that the majority of dhap 
was metabolized to 12ppd-R in uTpiA compared to lac-DL in eTpiA strains. 
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Known mechanisms of methylglyoxal toxicity 
Mechanisms of methylglyoxal toxicity are known and enable deeper interpretation of the multi-
omic data set generated (discussed in the sections below).  We thus describe them briefly.  
Methylglyoxal is capable of attacking exposed nucleotides of single stranded RNA or DNA 
(Krymkiewicz, 1973), particularly at guanosine bases (Broude and Budowsky, 1971) (Fig. 4B).  
This toxicity has been shown to severely inhibit DNA replication through methylglyoxal cross 
links formed between guanosine residues of DNA and lysine and/or cysteine residues of the 
DNA polymerase (Murata-Kamiya and Kamiya, 2001).  Methylglyoxal is also capable of 
oxidizing amino acids of RNA or DNA via Fenton’s reaction (Imlay and Linn, 1988; Kang, 2003). 
 
Methylglyoxal damage is not limited to nucleotides, but extends to proteins and peptides.  The 
thiol of cysteine groups is susceptible to form methylglyoxal  induced hemithioacetal adduct 
cross links with nearby peptide strands or glutathione (Ridderström and Mannervik, 2002) (Fig. 
4C).  Methylglyoxal can form lysine-lysine cross links via the Maillard Reaction (Nagaraj et al., 
1996) (Fig. 4D).  In addition to lysine, methylglyoxal has been shown to bind and modify 
arginine and cysteine residues (Lo et al., 1994).  The glycation of lysine in particular has been 
shown to generate superoxide anions that are then capable of causing additional damage 
(Kang, 2003) (Fig. 4D).   The mechanisms by which methylglyoxal  damages proteins and 
peptides has been shown to be capable of inhibiting enzymatic function in vitro and in vivo 
(Kalapos, 1994). 
 
ROS generated through Fenton Reactions involving methylglyoxal can lead to DNA strand 
breaks (Fig. 4E).  2-phosphoglycolyate is formed during repair of DNA strand breaks (Fig. 4F).  
2-phosphoglycolyate can then be broken down by phosphoglycolate phosphatase (Gph) to 
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glycolate (glyclt) and inorganic phosphate (pi).  In addition, methylglyoxal forms abducts with 
dATP and dGTP (Frischmann et al., 2005; Papoulis et al., 1995). 
 
Elevated methylglyoxal induced global stress responses  
Global stress responders were activated in uTpiA (Fig. 4H). Expression of rpoS was significantly 
increased in uTpiA compared to Ref (Fig. 4H).  rpoS encodes an alternative sigma factor to 
rpoD that acts as a master regulator of general stress response that is itself induced during 
times of stress (see (Landini et al., 2014) for a review).  Many universal response genes were 
also activated.  uspB, uspD, uspF, and uspG were all significantly upregulated in uTpiA 
compared to Ref (Fig. 4H).   
Elevated methylglyoxal activated glycation responses  
Evidence for methylglyoxal damage to and glycation of DNA was revealed by expression 
profiling (Fig. 4H).  Numerous chromosomal toxin-antitoxin (TA) pairs were found to be activated 
in uTpiA.  Chromosomal TA systems respond to DNA damage and nutrient limitation by 
suppressing protein synthesis and promoting cell motility and biofilm formation (Magnuson, 
2007; Ramisetty and Santhosh, 2017).  Activation of chromosomal TA pairs have been shown 
to be associated with persister phenotypes (Kim and Wood, 2010; Luidalepp et al., 2011). TA 
pair mqsR/mqsA was significantly upregulated in uTpiA compared to Ref (Fig. 4H).  mqsR 
inhibits protein synthesis by cleaving mRNA at GCU sites (Yamaguchi et al., 2009).  
Overexpression of mqsR induces expression of cspD, which was also significantly upregulated 
in uTpiA (Kim et al., 2010).  cspD inhibits DNA replication and increases persister cell formation 
(Kim and Wood, 2010).  TA pair yafQ/dinJ was significantly upregulated in uTpiA compared to 
Ref (Fig. 4H).  yafQ inhibits protein synthesis by interacting with the 50S subunit of the ribosome 
where it cleaves mRNAs at AAA codons (Motiejūnaitė et al., 2007; Prysak et al., 2009).   
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Elevated methylglyoxal activated ROS responses  
Evidence for iron oxidation caused by ROS attack via Fenton’s reaction on iron-sulfur clusters  
was found in the transcriptomics data.  Evidence included shifts in the primary ribonucleotide 
reductases.  E. coli has two ribonucleotide diphosphate reductases that are encoded by nrdAB 
and nrdEF that operate under aerobic conditions and a ribonucleotide triphosphate reductase 
encoded by nrdDG that operates under anaerobic conditions (Brown et al., 1969; Hantke, 
1988).  The ribonucleotide di-/tri-phosphate reductases act to generate deoxynucleotides for 
DNA and RNA synthesis (Torrents, 2014).  Of the aerobic ribonucleotide reductases, nrdEF 
expression is induced under oxidative stress when iron is unavailable to activate nrdAB (Martin 
and Imlay, 2011; Monje-Casas et al., 2001).  The entire nrdHIEF operon was significantly 
upregulated in uTpiA compared to Ref (and eTpiA strains) (Fig. 4H), while nrdA was significantly 
downregulated in uTpiA compared to Ref.  Fur appeared to be activated based on expression 
profiles of the small regulatory RNA rhyB.  rhyB was upregulated in uTpiA compared to Ref (and 
eTpiA strains).   
 
The manganese importer encoded by mntH was upregulated in uTpiA compared to ref (and 
eTpiA strains) (Fig. 4H).  mntH is regulated by OxyR, Fur, and MntR,  and its expression is 
induced under iron starvation (Anjem et al., 2009).  All genes of the sufABCDSE operon except 
sufC and sufS were upregulated in uTpiA. compared to Ref (and eTpiA strains).   The genes of 
the sufABCDSE operon encodes enzymes that compose an alternative Fe-S cluster biogenesis 
pathways that is activated in times of oxidative stress and iron starvation (Lee et al., 2004; 
Outten et al., 2004).  In contrast, the primary Fe-S cluster biogenesis pathway encoded by the 
ICS system was upregulated in eTpiA strains (Fig. 4H. Table S4) (Kim et al., 2014; Roche et al., 
2015; Tokumoto et al., 2002).      
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Elevated methylglyoxal activated nucleotide synthesis responses  
Expression of nucleotide synthesis and salvage pathways were massively perturbed in uTpiA 
(Table S5, pvalue < 0.05, topGO, ParentChild, Fischer).  The majority of nucleotide synthesis 
and salvage pathways were significantly down-regulated in uTpiA compared to Ref (and eTpiA 
strains) (Table S4).  Metabolomics also revealed massive perturbations in nucleotides, 
nucleosides, and nucleobases.  In fact, almost all nucleotides, nucleosides, and nucleobases 
assayed were significantly changed in uTpiA compared to Ref (and eTpiA strains) (Fig. 4G, 
Table S3).  For example, a significant drop in ATP (-0.68 log2 fold change compared to Ref) 
resulted in a significant drop in the Energy Charge ratio in uTpiA (from 0.90 in Ref to 0.82) 
(Table S3).  In addition, nucleotide triphosphates GTP, ITP, UTP, dTTP, and dUTP were 
significantly depleted; nucleotide diphophosphates GDP, UDP, and dADP were significantly 
perturbed; nucleotide monophosphates CMP, dIMP, and dCMP were significantly changed; and 
nucleobases nucleotides Adenine, Guanosine, Hypoxanthine, Inosine, and Uridine were 
significantly perturbed in uTpiA compared to Ref (Fig. 4G, Table S3).  These large changes in 
the nucleotide pools at all levels of phosphorylation could be indicative of perturbations of not 
just de novo synthesis and salvage, but also potentially break down from DNA, RNA, or direct 
attack by methylglyoxal. 
 
Taken together, elevated methylglyoxal levels activated a number of stress responses that are 
consistent with reported detoxification responses.  These responses were characterized in more 
detail here than in previous studies, and not only did they reveal mechanistic details and the 
global nature of the response, but their characterization provided the necessary starting point for 
the interpretation of the adjustments made during the ensuing ALE experiment.  
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ALE alleviated glyoxalase repression increasing flux through the 
methylglyoxal pathway 
Path 4 relies on the Glyoxalase enzymes encoded by gloAB (Fig. 3A, Fig 5).  Glyoxalase 1 
binds methylglyoxal with Reduced Glutathione (gthrd) to form S-D-lactoyl-glutathione (lgt-S) 
(Thornalley, 2003) (Fig. 3A).  Glyoxalase 2 then regenerates gthrd from lgt-S while 
enzymatically generating lac-D (Vander Jagt, 1993) (Fig. 3A).  Expression of gloA is repressed 
by NemR (Fig. 5A-B); repression is enhanced by elevated levels of mthgxyl (Ozyamak et al., 
2013; Umezawa et al., 2008) (Fig. 5C).  A mutation in the nemR promoter region in eTpiA03, 
and mutations in the nemR small-molecule-binding domain or tetramerization regions in 
eTpiA01, 02, and 04 were found to offset NemR repression, and allowed for increased 
expression of gloA (Fig. 4A-D).   
 
The increased expression of gloA appeared to have provided a fitness advantage by increasing 
the flux capacity of the methylglyoxal pathway (Fig. 2B). The enhanced conversion of dhap to 
lac-DL and subsequent conversion of lac-DL to pyr (Fig. 2E) substantially increased the levels 
of both lac-DL and pyr in eTpiA strains.   The levels of lac-DL were 8.65, 8.37, 8.34, and 8.72 
log2 fold change in eTpiA strains, respectively, compared to uTpiA, while levels of pyr were 
10.39, 10.12, 10.08, and 10.47 log2 fold change in eTpiA strains, respectively, compared to 
uTpiA.  In particular, the levels of pyr were severely depleted in uTpiA due to the forced 
bifurcation of flux that resulted from the loss of the TPI.  The levels of pyr were -4.51 log2 fold 
change less in uTpiA compared to Ref.  Unconverted lac-DL was excreted by the eTpiA strains 
(Fig. 1 D).  In addition, the increased activity of the Glyxylase system also led also lead to an 
elevation in methyglyoxal derived detox products (Fig S2). 
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Transcription factor cross-talk induced expression of phosphate 
starvation pathways 
Phosphate import in E. coli is tightly regulated by the PhoB/PhoR two component system (TCS) 
(Hsieh and Wanner, 2010) (Fig. 6A).  Signalling by the PhoBR TCS involves the high affinity 
ABC phosphate transporter encoded by the pstSCAB operon and a regulatory protein encoded 
by phoU (Aguena et al., 2002; Gardner et al., 2014) that coordinate phosphate import with 
phosphate metabolism (Fig. 6A).  When extracellular phosphate levels are high, 
phosphorylation and activation of PhoB by PhoR is inhibited by PhoU; when extracellular 
phosphate levels are low, PhoR phosphorylates and activates PhoB (Fig. 6A).  Phosphorylated 
PhoB then activates numerous operons believed to be involved in phosphate metabolism (Baek 
and Lee, 2007; Hengge, 2009; Yang et al., 2012).  Among these is the phn operon that encodes 
genes required to metabolize methylphosphonate (Kamat et al., 2011; Metcalf and Wanner, 
1993), which provides a source of phosphate under conditions of phosphate starvation (Metcalf 
and Wanner, 1993). 
 
The majority of phoB controlled operons were upregulated in uTpiA compared to Ref (Fig. 6H, 
Table S4).  The genes of the phn operon were massively upregulated in uTpiA.  A majority of 
other experimentally verified genes controlled by phoB were also significantly differentially 
expressed in uTpiA (Fig. 6H, Table S4).  Given the tightly controlled amount of phosphate in the 
cultivation medium, lack of phosphate would seem improbable.  However, cross-talk between 
other histidine kinases including CreC and KpdD have been experimentally verified (Wanner, 
1993).  Targets of CreB, the TF pair of the CreCB TCS, including all genes of the malEFG 
operon, recG, spoT, trmH, recG, and talA were all differentially expressed in uTpiA compared to 
Ref (Table S4).  The only known target of KpdE, the kdpFABC operon was not differentially 
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expressed.  KpdE is the TF of the KpdDE TCS. Most probable given the expression of PhoB, 
CreB, and KpdE gene targets was cross-talk between CreC and PhoB.  CreB is activated during 
the fermentation of glycolytic carbon sources that produce short chain organic acids such as 
12ppd-R, lac-DL, and pyr (Cariss et al., 2008). 
The PhoBR two component system and PST Pi ABC transporter 
were mutation hotspots during ALE 
A series of mutations were found in phoB, phoR, and pstA that altered expression of genes of 
the PhoB regulon (Fig. 6B-F).  pstA was mutated in all eTpiA strains (Fig. 6F).  The mutation 
truncated the transmembrane protein PstA from 286 to 38 residues.  Given that the PstA 
component is an integral part of the PST ABC transporter, it would seem likely that the 
truncation would inhibit the ability to transport phosphate, and would disrupt normal complex 
formation.  The PST ABC transporter is the primary phosphate transporter in E. coli (Beard et 
al., 2000; Harris et al., 2001; Jackson et al., 2008).  Loss of any of the PST components has 
been shown to change interaction of PstB with PhoU, leading to changes in phosphorylation 
patterns of PhoB by PhoR (Chekabab et al., 2014).  Deletion of the PST system has been 
associated with virulence in Extraintestinal pathogenic E. coli (ExPEC) (Crépin et al., 2012; 
Daigle et al., 1995; Glattard et al., 2010; Lamarche and Harel, 2010). 
 
Mutations were found in either phoB or phoR that fixed in eTpiA02, 03, and 04 strains, while 
lower frequency mutations were found in phoB and phoR in eTpiA01 (Fig. 6B-D).  These 
mutations targeted the PhoB TF binding site of the phoBR operon (Fig. 6B), altered  the amino 
acid sequence of PhoB (Fig. 6C), shortened the length of the PhoR peptide (Fig. 6D), or hit the 
phoB response regulatory domain (Fig. 6E).  The mutations in eTpiA02 and 03 resulted in the 
most deactivation of PhoB regulation, while the mutations in eTpiA01 and eTpiA04 retained 
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similar expression profiles to that of uTpiA (Fig. 6H).   Interestingly, expression patterns of CreB 
targets in eTpiA01 and eTpiA04 also showed similar expression profiles to that of uTpiA 
indicating continued cross-talk with CreC (Table S4). 
Bifurcated glycolytic flux perturbed energy and redox carrier 
balances, which lead to a global rerouting in the flux map to 
regain optimal growth 
While lower glycolysis generates four energy equivalents (i.e., ATP) and two redox equivalents 
(i.e., NADH), the methylglyoxal pathway generates a toxic intermediate (i.e., methylglyoxal) and 
burns zero to two redox equivalents (i.e., NADH, NADPH, Reduced Glutathione) depending 
upon the pathway used. Consequently, levels of ATP were significantly depleted in uTpiA (-0.74 
log2 fold change compared to Ref), which lead to a significant drop in the energy charge ratio 
(from 0.90 in Ref to 0.82) (Table S3).  In addition, lower glycolytic intermediates including 1-3/2-
3 diphosphoglycerate (13/23dpg), 2/3-phosphoglycerate, (2/3pg), pep, and pyr were severely 
depleted in uTpiA (-1.39, -2.62, -1.47, and -4.51 log2 fold change compared to Ref) (Table S3).  
 
In particular, the depleted levels of pep appeared to be most detrimental to growth, and required 
major adjustments to all reactions and subsystems that involved pep.   These included 
mutations to the Phosphotransferase System (PTS) and lower glycolytic enzymes.  Major 
adjustments in flux also extended to subsystems that do not directly involve pep, but contributed 
flux to or from the pep node.  These included upper glycolysis, the pentose phosphate pathway 
(PPP), and the TCA cycle.  These adjust are detailed below. 
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Systematic decoupling of pep production from glucose import and 
cell wall recycling occurred during ALE 
A host of mutations involving ptsG, galR, and nagA, nagC, and nagE in the eTpiA strains were 
found that appeared to systematically decouple pep consumption from carbon import.  
Mutations that altered the expression and function of nAcGam import and catabolic genes were 
found in eTpiA02/04 strains (Fig. 7). The nagBAC and nagE operons are negatively regulated 
by the NagC TF (Fig. 7A).  EIIB encoded by nagE of the nAcGam PTS Permease imports and 
phosphorylates periplasmic N-acetyl glucosamine (Fig. 7B). The phosphate is derived from the 
conversion of phosphoenolpyruvate (pep) to pyruvate (pyr) after a series of phosphorylation 
reactions along the PTS components EI, HPr, and EIIA.  N-acetyl glucosamine 6-phosphate 
(acgam6p) is then broken down to nitrate (nh4) and fructose-6-phosphate (f6p) by N-
acetylglucosamine-6-phosphate deacetylase (AGDC) encoded by nagA and Glucosamine-6-
phosphate deaminase (G6PDA) encoded by nagB (Fig. 7B).  The genes that compose the 
nagBAC and nagE operons contribute to a significant recycling of peptidoglycan (Plumbridge, 
2009).  All nagC mutations in eTpiA02/04 appeared to be deleterious resulting in truncated 
peptides (Fig. 7C).  The nagC mutations relieved NagC repression of the nagBAC and nagE 
operons, resulting in significantly higher expression in eTpiA02/04 (Fig. 7D).  Increased 
expression appeared to be offset by mutations that prevent import and phosphorylation of 
acgam by nagE.  The nagE mutations occur in the PTSEIIC type-1 complex formation region 
and resulted in amino acid changes that could have affected activity (Table S8).     
  
Mutations that increased expression of non-PTS glucose importers occurred in eTpiA01/03 
strains (Fig. 8).  The primary importer of glucose in E. coli is the PTS, which is similar to the 
nAcGam PTS imports and phosphorylates glucose at the expense of pep (Fig. 8A).  Specifically, 
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glucose is imported and phosphorylated from the periplasm into the cytosol by EIIB encoded by 
ptsG.  Alternative passive (i.e., D-galactose symporter encoded by galP) and active importers 
(i.e., D-galactose ABC transporter encoded by mglBAC) utilize the proton gradient or ATP, 
respectively, to import glucose (Fig. 8B).  Passive and active importers are regulated by the 
GalR and GalS TFs (Fig. 8C).  Mutations in galR in eTpiA01/03 appeared to alter activity so as 
to increase expression of galETKM and passive importer encoded by galP, but not active ATP-
dependent importer encoded by mglBAC (Fig. 8F).  In addition, a galP INS mutation occurred at 
the NagC binding site in eTpiA01, further indicating an adaptive preference for passive import 
overactive import (Fig. 8D).  Note that eTpiA01 had the highest level of expression of galP.    
 
Complementary mutations in eTpiA01/03 occurred in ptsG in that appeared to abolish import 
and phosphorylation activity of the primary PTS-dependent glucose importer.  The ptsG SNP 
mutation in eTpiA01 introduced a stop codon that truncates the cytosolic portion of the protein 
including the PTS EIIB type-1 active site and phosphocysteine residue (Fig. 8E).  The ptsG INS 
mutation (not shown in the figure) introduced an additional codon that shifted all residues by one 
in the PTS EIIB active site, which could have altered activity (Table S8).  
Additional systematic decoupling of pep enzymatic reactions  
In addition to carbon import processes, other enzymatic reactions that consume pep were also 
targeted by mutations.  Mutations were found in pykF and murA that potentially affected 
enzymatic function (Fig. 9).   Pyruvate kinase (PYK) is encoded by pykF or pykA and converts 
pep to pyr while generating ATP (Fig. 9A).  Mutations found in pykF in eTpiA02, 03, and 04 
were most likely deleterious (Fig. 9B).  The pykF MOB resulted in a truncated peptide that 
removed all features except for two potassium ion binding sites and a substrate binding residue.  
The pykF DEL was located at the interface between the dimers, and resulted in a frameshift that 
 16 
 
shifted the stop codon beyond the normal length of the peptide that most likely generated an 
aggregate peptide.  The pykF SNP changed the 226 residue from G to D, and was located in 
close proximity to the magnesium binding site residues.  UDP-N-acetylglucosamine 1-
carboxyvinyltransferase (UAGCVT), encoded by murA, converts UDP-N-acetyl-α-D-
glucosamine (uacgam) to UDP-N-acetyl-α-D-glucosamine-enolpyruvate (uaccg) at the expense 
of pep in the first committed step to peptidoglycan biosynthesis (Fig. 9C).  The murA DEL in 
eTpiA04 resulted in a non-frameshift that shortened the peptide by one amino acid (Fig. 9D).  
Interestingly, the mutation changed the cysteine residue at position 115, which interacts with 
pep.  The 115 residue has been actively investigated for implications in drug discovery 
(Bachelier et al., 2006; Barbosa et al., 2002; Baum et al., 2001; Couce et al., 2012; Desai and 
Miller, 2010; Dunsmore et al., 2008; Francisco et al., 2004; Kim et al., 1996; Miller et al., 2010; 
Xu et al., 2006).   
Multiple pathway flux adjustments during ALE balanced 
methylglyoxal generation with biosynthesis 
Bifurcation of lower glycolysis coupled glucose metabolism to the generation of the toxic 
intermediate methylglyoxal.  A complete rewiring of metabolic flux through central metabolism 
was required for the eTpiA strains to recover approximately 50% of the growth rate of Ref.  
Notable shifts in flux were found in the pentose phosphate pathway (PPP), lower glycolysis, flux 
into the TCA cycle either through the anaeplerotic reaction Phosphoenol Pyruvate Carboxylase 
(PPC) or Citrate Synthase (CS), and utilization of the glyoxylate shunt.  A 5.14 log2 fold change 
in flux per mol glucose through the Entner–Doudoroff (ED) pathway compared to Ref in uTpiA  
shifted to 3.60, 2.46, 3.36, and 4.76 log2 fold change in eTpiA strains, respectively.  A -1.69 
log2 fold change in flux per mol glucose through PYK compared to Ref in uTpiA shifted to -5.94, 
-5.49, -6.36, and -4.49 log2 fold change in eTpiA strains, respectively.  The relative drop in PYK 
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flux in many of the endpoints could in part be attributed decreased expression, but also due to 
mutations found in the pykF gene (discussed previously).  The majority of pyr levels were 
recovered through the rejoining of flux through the methylglyoxal pathway instead of through 
PTS reactions and PYK.  A 1.7 mmol*gDCW-1*hr-1 flux in from lac-DL to pyr in uTpiA increased 
to 4.9, 6.2, 4.7, and 2.5 in eTpiA strains, respectively.  
 
Overall flux into the TCA cycle per mol of glucose dropped in all eTpiA strains.  An initial  90% 
relative boost per mole of glucose in PPC flux compared to Ref in uTpiA was lost to a -54%, -
15%, -49%, and -31% relative drop in eTpiA strains, respectively.  An initial 182% relative boost 
per mole of glucose in CS flux compared to Ref in uTpiA was reduced to 17%, 96%, 34%, and 
90% in eTpiA strains, respectively.  In addition, partial utilization of the glyoxylate shunt was 
restored in eTpiA strains.  A -94% relative change per mole of glucose through the glyoxylate 
shunt compared to Ref in uTpiA was increased a to 57%, 58%, 103%, and 52% in eTpiA 
strains, respectively. 
 
The above shifts in flux appeared to simultaneously increase flux through lower glycolysis (i.e., 
increased flux through ED) to increase the levels of lower glycolytic intermediates and 
generation of ATP and redox equivalents while minimizing glycolytic flux that would commit 1 
mol of glucose to methylglyoxal generation.  In addition, the above shifts in flux also maximized 
pyr production while minimizing pep consumption resulting in an overall loss in flux through the 
TCA cycle.  Interestingly, while many of the redox ratios were recovered, the energy charge 
ratio was never recovered (Table S3), indicating that the coupling of biomass production to 
methylglyoxal production induced an intrinsic cost to energy production. 
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Conclusion 
Flux through glycolysis was stoichiometrically coupled to the production of the toxic metabolite 
methylglyoxal in E. coli by removing the tpiA gene.  Production of methylglyoxal resulted in 
cellular damage that was overcome through efficient detoxification by the Glyoxalase enzymes.  
Elevation in the end-products of the methylglyoxal pathway, 12ppd-R and lac-DL, triggered an 
erroneous phosphate starvation response via cross talk with CreCB TCS that was dampened 
through mutations that affect PhoB signalling.  Split flux through lower glycolysis depleted 
glycolytic intermediates, in particular, pep.  Pep levels were restored to levels similar to Ref 
through mutations that decoupled pep production from carbon import.  The detoxification 
strategy of methylglyoxal and network changes required an increase in carbon import without 
exacerbating methylglyoxal toxicity or depletion of glycolytic intermediates that serve as key 
biomass precursors. Thus, multi-omics analysis and ALE confirmed in higher resolution than 
previously reported methylglyoxal toxicity responses and revealed novel biochemical 
mechanisms that should provide researchers with valuable insights into strategies deployed for 
metabolic detoxification in bacteria.   
 
Taken together, this study shows that the combination of KO, multi-omic data analysis and ALE 
represent a new line of biological inquiry.  It reveals the full consequences of the loss of a gene 
product and the genetic changes needed to regain fitness.  This overall conclusion provides an 
impetus to perform analogous studies for a series of major gene products in E. coli.  Such 
studies would provide us with a new and deep understanding of the systems biology of basic 
regulatory and metabolic processes in bacteria. 
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Fig. 1 Evolution of knockout (KO) strains from a pre-evolved (i.e., optimized) wild-type strain.  A)  
Wild-type (wt) E. coli (MG1655 K-12) was previously evolved on glucose minimal media at 
37oC(LaCroix et al., 2015).  An isolate from the endpoint of the evolutionary experiment was 
selected as the starting strain for subsequent KO of tpiA and adaptive laboratory evolution 
(ALE).  B) Adaptive laboratory evolution trajectories of the evolved knockout lineages.  -Omics 
data collected included metabolomics, fluxomics, physiology, DNA resequencing, and 
transcriptomics.  C) Triosephosphate isomerase (TPI) was disabled by the gene KO.  TPI 
interconverts the triosephosphate dihydroxyacetone phosphate (dhap) to glyceraldehyde 3 
phosphate (g3p).   Additional metabolites shown for context include D-glucose (glc-D), glucose 
6-phosphate (g6p), ribulose 5-phosphate (ru5p-D), methylglyoxal (mthgxl), 
phosphoenolpyruvate (pep), pyruvate (pyr), DL-lactate (lac-DL),acetate (ac), alpha-ketoglutarate 
(akg), and succinate (succ).  D) Growth rate and uptake and secretion rates of D-glucose, 
acetate, and DL-lactate for unevolved KO (uTpiA) and evolved KOs (eTpiA). 
Fig. 2 The removal of triose phosphate isomerase (TPI) forced a bifurcation of flux in glycolysis 
through a pathway that involved the toxic intermediate methylglyoxal (mthgxl) (panels A-E).  The 
bifurcated flux is rejoined by the lactate dehydrogenase (LDH) reaction.  A) A network 
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schematic of middle glycolysis.  Shown along with removed TPI (shown in red) are the reactions 
catalyzed by fructose bisphosphate aldolase (FBA), glyceraldehyde 3-phosphate 
dehydrogenase (GAPD), and methylglyoxal synthase (MGSA). B) Flux levels of reactions 
derived from C13 labeling experiments near the gene knockout.  C) Network schematic of lactate 
and pyruvate conversion.  D) Regulatory schematic showing the feedback loop that up-
regulates the conversion of D/L-Lactate to pyruvate when elevated levels of intracellular lactate 
were sensed by the transcription factor lldR.    E) Metabolite, expression, and measured flux 
levels involved in the regulatory feedback loop.  
Fig. 3 Optimization of methylglyoxal detoxification pathway expression in tpiA lineages. Paths 1, 
2, and 3 were actively expressed in uTpiA, while path 4 was not.  Through fixed mutations that 
affected gloA expression, path 4 was expressed in the eTpiA endpoints.  A) Network diagram of 
the four methylglyoxal detox pathways in E. coli.  B) Expression profiles of methylglyoxal detox 
pathway genes. Path 1: fucO and gldA are up regulated in uTpiA compared to all eTpiA strains; 
yqhD and dkgA are up regulated in uTpiA compared to Ref and are up regulated in most eTpiA 
strains compared to uTpiA;  Path 2: AldA is up regulated in uTpiA compared to Ref and in most 
eTpiA strains compared to Ref, but down regulated in all eTpiA strains compared to uTpiA.  
Path 3: HchA is significantly elevated in uTpiA compared to all eTpiA strains and Ref; yhbO is 
up regulated in eTpiA 3 compared to Ref.  Path 4: GloA is up regulated in all eTpiA strains 
compared to Ref and uTpiA.  Up/Down regulation p-value < 0.05. 
Fig. 4 Select mechanisms of methylglyoxal (mg or mthgxl) attack on cellular components.   A) 
ball and stick diagram of methylglyoxal.  Methylglyoxal contains two reactive carbonyls: an 
aldehyde and a ketone.  Methylglyoxal exerts its toxicity through damage of cellular components 
with which it interacts.  B) methylglyoxal cross-links single stranded RNA or DNA (shown) 
and/or peptides (shown in D) with other peptides between a RNA/DNA base and/or sulfur 
residues and lysine residues through formation of a imidazolysine group via the Maillard 
reaction (Broude and Budowsky, 1971; Krymkiewicz, 1973; Lo et al., 1994; Murata-Kamiya and 
Kamiya, 2001).  C) methylglyoxal forms adducts with sulfur residues of enzymes directly that 
can inhibit their function (Kalapos, 1994; Ridderström and Mannervik, 2002).  D)  methylglyoxal 
participates in the formation of free radicals and reactive oxidative species (ROS) through 
glycation of amino acids (shown) or nucleotide bases (not shown) via Fenton’s Reaction (Cadet 
et al., 2003; Cooke et al., 2003; Imlay and Linn, 1988; Kang, 2003).  E) The generated ROS is 
then capable of inducing single stranded DNA or RNA (ssRNA/ssDNA) breaks.  F)   ROS 
attacks the ssRNA or ssDNA backbone generating 2-phosphoglycolate (2pgblyc) a 
deoxynucleotide and a nucleotide base.  G) Metabolite concentrations of nucleobases, 
nucleotides, and mono-, di-, and tri- nucleotide phosphates.  H) RNA expression profiles of 
select genes that respond to cellular stress and ROS. 
Fig. 5 Mutations that affect the transcription factor NemR that allowed for expression of the gloA 
detox pathway(Ozyamak et al., 2013).  A) Crystal structure of the nemR multimer (Gray et al., 
2015).  A mutation that alters NemR binding to the regulatory region are annotated in red.  
Chains A, B, C, and D are highlighted in gold and grey; the regulatory region is highlighted in 
cyan; mutations are annotated in red. B) Reorientation and zoom in on two of the nemR 
multimer chains.  C)  Schematic of the nemRA-gloA operon (see Fig. 6 for expression profiles of 
the methylglyoxal detox pathways).  NemR exerts negative feedback on the operon that is 
enhanced by increased levels of methylglyoxal (mthgxl) (Ozyamak et al., 2013; Umezawa et al., 
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2008).  gloA is co-expressed with nemR and nemA genes.  D)  Mutation frequency and 
expression profiles of nemR and nemR-associated genes.  The lineages with mutations have 
significantly increased expression of the gloA detox pathway (p-value < 0.05).   
 
Fig. 6 A host of mutations targeted elements of the phosphate starvation response regulon, 
including the PhoRB two component system (TCS) and the Pst phosphate ABC transporter.  A) 
The PhoRB two component system (TCS) senses and responds to the absence of extracellular 
inorganic phosphate (Pi), and is composed of a transmembrane sensory histidine kinase (PhoR) 
and transcription factor (PhoB).  The PhoRB signalling processes are mediated by an ABC 
(ATP-dependent) transporter encoded by pstS, pstC, pstA, and pstB, that imports Pi as well as 
a  chaperone-like inhibitory protein (PhoU) that physically interacts with the cytosolic portion of 
the Pst Pi ABC transporter (PstB) and PhoR.  In the presence of extracellular Pi (Pi 
concentration approximately > 4 uM), the extracellular portion of the Pst Pi ABC transporter 
(PstS) is saturated.  This leads to a signal transduction mediated by PhoU that leads to a 
conformational change of PhoR into an inactive state.  Under conditions of phosphate limitation 
or in the absence of any of the Pst components, PhoR returns to its default active conformation, 
where it is able to phosphorylate and activate PhoB.  B) Operon diagram for phoB.  An 11 
nucleotide deletion occurred at the PhoB TF binding site (sbcD-/-phoB (DEL) 416288 ∆11nt) in 
eTpiA03.  C) A 1 nucleotide deletion at the 205 residue in phoB (phoB (DEL) 205∆1nt) in 
eTpiA03 in 61.3% of the population resulted in a frameshift that changed all amino acids from 
the site of the mutation to the end of the peptide.  Interestingly, the peptide length was not 
changed.  D) phoR encodes the transmembrane sensory histidine kinase component of the 
PhoRB TCS.  Two, most likely deleterious mutations, targeted phoR.  The phoR deletion at the 
180 residue (phoR (DEL) 180∆1nt) in eTpiA01 affected 53.2% of the population, and resulted in 
a frameshift that truncated the peptide at the 187 residue, cleaving the phosphohistidine and 
histidine kinase residue and domains, respectively.  The phoR deletion at the 358 residue (phoR 
(DEL) 358∆1nt) in eTpiA04 resulted in a frameshift that truncated the peptide at the 368 residue, 
cleaving the histidine kinase domain, but leaving the phosphohistidine regulatory regions intact.  
E) Crystal structure of PhoB (Solá et al., 1999).  PhoB is the response regulator (i.e., TF) 
component of the PhoRB TCS, and induces or represses operons of the Pho regulon.  An SNP 
in phoB (phoB (SNP) A84P) occurred in eTpiA01 that affected 52.9% of the population.  The 
mutation is located near the L105 residue that binds magnesium (mg2+), which may affect 
magnesium binding.  The phoB deletion at the 39 residue (phoB (DEL) 39∆17nt) in eTpiA03 
resulted in a frameshift that truncated the peptide at the 89 residue.  The phoB deletion at the 
76 residue (phoB (DEL) 76∆5nt) in eTpiA02 resulted in a frameshift that truncated the peptide at 
the 93 residue.  Mutations are highlighted in red.  The bound magnesium is shown in green.  F) 
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pstA encodes a transmembrane component of the phosphate ABC transporter, which imports 
extracellular phosphate at the expense of ATP.  A deleterious 774 nucleotide deletion in pstA 
(pstA (DEL) 1∆774nt)  truncated the peptide to all but 38 amino acids.  Loss of any of the Pst 
components has been shown to lead to a perpetual activation of the PhoRB TCS. G) Regulatory 
diagram of operons controlled by PhoB.  H) Mutation frequency and expression of genes 
involved in phosphate starvation response regulon.  Note that the majority of genes in the Phn 
and Pho operon are significantly elevated in uTpiA.  See Table S4 for a comprehensive list of all 
significant changes in gene expression. 
Fig. 7 Mutations that altered expression and function of nAcGam import and catabolic genes. A) 
Schematic of the nagBAC (catabolic enzymes) and nagE (PTS-specific component) operons.  
B) A network and mechanistic schematic of the nAcGam PTS Permease.  N-acetyl glucosamine 
is imported from the periplasm and phosphorylated by EIIB (encoded by nagE.  The phosphate 
is derived from the conversion of phosphoenolpyruvate (pep) to pyruvate (pyr) after a series of 
phosphorylation reactions along the PTS components EI, HPr, and EIIA.  N-acetyl glucosamine 
phosphate (acgam6p) is then broken down to nitrate (nh4) and fructose 6-phosphate (f6p) by N-
acetylglucosamine-6-phosphate deacetylase (AGDC) encoded by nagA and Glucosamine-6-
phosphate deaminase (G6PDA) encoded by nagB.  C) Crystal structure of NagC.  The majority 
of the nagC mutations appeared to be deleterious.  The nagC mobile element insertion (MOB) 
mutation truncated the peptide from 409 AAs to 339 AAs.  The nagC insertion (INS) mutation 
truncated the peptide from 409 to 96 AAs.  The nagC SNP mutation results in a change of 
amino acids from D to V.  Mutations are highlighted in red, orange, and yellow.  The DNA 
binding region is highlighted in cyan.  The nagE mutations (not shown) occurred in the PTSEIIC 
type-1 complex formation region and resulted in amino acid changes (Table S8).  The nagA 
SNP mutations (not shown) all resulted in amino acid changes (Table S8).  The nagA MOB was 
most likely deleterious, and truncated the peptide from 382 to 168 AAs (Table S8).  D) Mutation 
frequency and expression profiles of nagBAC and nagE genes.  Note that nagE and nagC were 
both mutated in eTpiA02/04, while lower level mutations in nagA  occured in eTpiA01/03.  While 
nagBAC and nagE are overexpressed in all eTpiA strains, eTpiA02/04 have significantly higher 
expression than eTpiA01/03.    
Fig. 8 Mutations that increased expression of non-PTS glucose importers.  Network and 
mechanistic schematic of the A) Glucose-specific PTS permease and B) passive and active 
glucose importers.  Glucose is imported and phosphorylated from the periplasm into the cytosol 
by EIIB encoded by ptsG.  C) Network schematic of operons regulated by GalR and GalS.  D) 
Regulatory schematic of the GalP operon.  The galP INS mutation occurred at the NagC binding 
site.  Note that eTpiA01 had the highest level of expression of galP.   E) crystal structure of the 
cytosolic portion of EIIA/B encoded by ptsG.  The ptsG SNP introduced a stop codon that 
truncated the cytosolic portion of the protein including the PTS EIIB type-1 active site and 
phosphocysteine residue.  The mutation is highlighted in red.  The crr interaction domain is 
highlighted with a bounding box.  The ptsG INS mutation (not shown) introduced an additional 
codon that shifted all residues by one in the PTS EIIB active site, which could have altered 
activity (Table S8). F) Crystal structure of GalR.  Mutations are highlighted in red.  The small 
molecule binding domain is highlighted in cyan.  The DNA binding region is highlighted in 
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magenta.  G) Mutation frequency and expression levels of genes that compose the glucose-
specific PTS as well as the D-galactose symporter and ABC transporter.  Note that The D-
galactose symporter and ABC transporter shown high affinity for glucose.  PtsG is down 
regulated in uTpiA and all eTpiA strains compared to Ref.  GalP is up regulated in eTpiA01 and 
03 strains compared to uTpiA and Ref while uTpiA is down regulated in uTpiA compared to Ref.  
GalU is down regulated in uTpiA compared to Ref.  GalS is up regulated in uTpiA and eTpiA 
strains compared to Ref.  GalETKM operon genes are all up regulated in eTpiA01 and 03 
strains.  Up/Down regulation p-value < 0.05. 
Fig. 9 Mutations that affect pykF and murA activity.   A) Network schematic of the PYK 
reactions.  B)  Crystal structure of PykF.  Mutations are annotated in red.  Substrate binding site 
residues are shown as ball and stick.  The magnesium and potassium ion binding sites are 
highlighted in blue.  The N6-acetyllysine residues are highlighted in cyan.  The pykF MOB 
resulted in a truncated peptide that removed all features except for two potassium ion binding 
sites and a substrate binding residue.  The pykF DEL was located at the interface between the 
dimers, and resulted in a frameshift that shifted the stop codon beyond the normal length of the 
peptide that most likely generated an aggregate peptide.  The pykF SNP changed the 226 
residue from G to D, and was located in close proximity to the magnesium binding site residues.  
C) Network schematic of the UAGCVT reaction encoded by murA.  D)   Crystal structure of 
MurA (Eschenburg and Schonbrunn, 2004).  The murA DEL resulted in a non-frameshift that 
shortened the peptide by one amino acid.  Interestingly, the mutation changed the cysteine 
residue at position 115, which interacts with pep.  The 115 residue in particular and murA as a 
whole has been actively investigated for implications in drug discovery (Bachelier et al., 2006; 
Barbosa et al., 2002; Baum et al., 2001; Couce et al., 2012; Desai and Miller, 2010; Dunsmore 
et al., 2008; Francisco et al., 2004; Kim et al., 1996; Miller et al., 2010; Xu et al., 2006).  The 
mutated residue is highlighted in yellow.  E) Mutation frequency, metabolite concentrations, 
expression, and metabolic flux derived from C13 labeling experiments of PYK and associated 
network components. 
Highlights:  
● tpiA Knockout-out in E. coli and adaptive laboratory evolution (ALE) 
● Consequences of methylglyoxal toxicity and mechanisms for detoxification revealed 
● Cross-talk between carbon starvation and inorganic phosphate signalling was uncovered 
● Counter intuitive inactivation of PTS required to rebalance the flux map 
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